Upstream Bio, Inc. SEC filings UPB
Upstream Bio, Inc. has 134 filings in SEC EDGAR's recent list, going back to Jun 12, 2024. Its latest annual report, Form ARS, was filed on Apr 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 1, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 1, 2026 | Sep 1, 2026 |
| 10-Q | Quarterly report | Aug 11, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2026 | Aug 11, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 10, 2026 | Jun 9, 2026 |
| 10-Q | Quarterly report | May 13, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 13, 2026 | May 13, 2026 |
| ARS | Annual report to shareholders | Apr 16, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 16, 2026 | — |
| DEF 14A | Proxy statement | Apr 16, 2026 | Jun 9, 2026 |
| 8-K |
Current report
Material agreement
|
Mar 26, 2026 | Mar 26, 2026 |
| 424B5 | Prospectus supplement | Mar 26, 2026 | — |
| S-8 | Employee stock plan registration | Mar 26, 2026 | — |
| 10-K | Annual report | Mar 26, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 26, 2026 | Mar 26, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 11, 2026 | Feb 11, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Feb 11, 2026 | Feb 11, 2026 |
| S-3ASR | Automatic shelf registration | Nov 5, 2025 | — |
| 10-Q | Quarterly report | Nov 5, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2025 | Nov 5, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 2, 2025 | Sep 2, 2025 |
| 10-Q | Quarterly report | Aug 6, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2025 | Aug 6, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 12, 2025 | Jun 10, 2025 |
| 10-Q | Quarterly report | May 6, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 6, 2025 | May 6, 2025 |
| ARS | Annual report to shareholders | Apr 17, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 17, 2025 | — |
| DEF 14A | Proxy statement | Apr 17, 2025 | Jun 10, 2025 |
| S-8 | Employee stock plan registration | Mar 12, 2025 | — |
| 10-K | Annual report | Mar 12, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 12, 2025 | Mar 12, 2025 |
| 10-Q | Quarterly report | Nov 7, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2024 | Nov 7, 2024 |
| SEC STAFF LETTER | Filing | Oct 16, 2024 | — |
| 8-K |
Current report
Bylaw or fiscal year change
|
Oct 15, 2024 | Oct 10, 2024 |
| S-8 | Employee stock plan registration | Oct 11, 2024 | — |
| 424B4 | Prospectus | Oct 11, 2024 | — |
| EFFECT | Filing | Oct 10, 2024 | — |
| S-1MEF | Filing | Oct 10, 2024 | — |
| CERT | Filing | Oct 10, 2024 | — |
| 8-A12B | Filing | Oct 8, 2024 | — |
| CORRESP | Letter to the SEC | Oct 8, 2024 | — |
| CORRESP | Letter to the SEC | Oct 8, 2024 | — |
| S-1/A | Amended registration statement | Oct 7, 2024 | — |
| CORRESP | Letter to the SEC | Sep 30, 2024 | — |
| CORRESP | Letter to the SEC | Sep 18, 2024 | — |
| S-1 | Registration statement | Sep 18, 2024 | — |
| UPLOAD | Letter from the SEC | Aug 20, 2024 | — |
| DRSLTR | Filing | Aug 9, 2024 | — |
| DRS/A | Filing | Aug 9, 2024 | — |
| UPLOAD | Letter from the SEC | Jul 25, 2024 | — |
| DRSLTR | Filing | Jul 18, 2024 | — |
| DRS/A | Filing | Jul 18, 2024 | — |
| SEC STAFF LETTER | Filing | Jul 9, 2024 | — |
| UPLOAD | Letter from the SEC | Jul 9, 2024 | — |
| DRS | Filing | Jun 12, 2024 | — |
Showing 56 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- UPB (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Waltham, MA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 2022626
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.